Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists-Reference-Cited by-同舟云学术

Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists

Published:2007-11 Issue:3 Volume:56 Page:308-316
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Carballo-Jane Ester,Gerckens Lynn S.,Luell Silvi,Parlapiano Allison S.,Wolff Michael,Colletti Steven L.,Tata James R.,Taggart Andrew K.P.,Waters M. Gerard,Richman Jeremy G.,McCann Margaret E.,Forrest Michael J.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference31 articles.

1. Studies on the mechanism of flush induced by nicotinic acid;Andersson;Acta Pharmacologica et Toxicologica (Copenhagen),1977

2. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing;Benyo;Journal of Clinical Investigation,2005

3. Potential role for epidermal Langerhans cells in nicotinic acid-induced vasodilatation in the mouse;Carballo-Jane;Inflammation Research,2007

4. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review;Carlson;Journal of Internal Medicine,2005

5. Nicotinic acid and other therapies for raising high-density lipoprotein;Carlson;Current Opinion in Cardiology,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation;Hypertension;2020-05

2. Influence of free fatty acids on glucose uptake in prostate cancer cells;Nuclear Medicine and Biology;2014-03

3. Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats;Journal of Pharmacokinetics and Pharmacodynamics;2013-07-04

4. Antilipolytic drug boosts glucose metabolism in prostate cancer;Nuclear Medicine and Biology;2013-05

5. (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans;Journal of Medicinal Chemistry;2012-04-09